Mergers and Acquisitions Services
Corporate Divestitures
InvestinPharma.com   assists companies in identifying and divesting non-core divisions or subsidiaries allowing companies to refocus on their long-term objectives and strengthen core competencies.

Fairness Opinions
InvestinPharma.com   creates fairness opinions to determine that the terms in a merger, acquisition, divestiture, securities issuance or other transaction are fair from a financial point of view. A fairness opinion may be rendered on behalf of a company, its shareholders or a limited group of shareholders (i.e. public shareholders or non-controlling shareholders). investinpharma.com approaches a fairness opinion/valuation from a financial standpoint, taking into consideration other factors including: management's objectives, a company's outlook, and industry conditions.

Leveraged buyout
InvestinPharma.com   assists investors in negotiating, financing and executing leveraged buyouts. We provide valuation recommendations, structuring alternatives, financing options, and representation in negotiating terms of the transaction.

Management Buyouts
InvestinPharma.com   assists management teams in negotiating, financing, and executing management buyouts. We provide valuation recommendations, deal structure recommendations, financing alternatives, and representation in negotiating terms of the transaction. In select transactions, Investinpharma.com will co-invest with management.

Mergers & Acquisitions
InvestinPharma.com   provides advisory services on a wide variety of transactions guiding clients through every phase of the M&A process, be it business brand or technology from the initial step of identifying a target through the negotiation, due diligence, financing and closing of the transaction we cover the entire spectrum. We provide both buy-side and sell-side advisory services as part of its M&A advisory offering.

 
     
  All rights reserved © 2009 Kegan Pharma Resources ( KPR ) Website Designed & Developed by Third Generation Resources Pvt. Ltd.